Celularity

CELUNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$20.282 M

$0.70 +2.59%

Close of 7 Aug 2026

Revenue

$26.6M

#2925 by revenue

Earnings

-$91.7M

Loss-making

Shares outstanding

28,945,961

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#396Cellectar BiosciencesCLRB$20.5M
#397Atossa TherapeuticsATOS$20.3M
#398CelularityCELU$20.3M
#399Werewolf TherapeuticsHOWL$19.3M
#400GridAI TechnologiesGRDX$18.9M

Where these numbers come from

Share counts and financials for Celularity are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.